Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

140 ARTÍCULOS , VIENDO DEL 1 AL 15

Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays

Lewczuk P, Lelental N, Spitzer P, Maler JM, Kornhuber J.

J Alzheimers Dis. 2015;43(1):183-91. doi: 10.3233/JAD-140771.

Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease

Schmidt C, Gerlach N, Peter C, Gherib K, Lange K, Friede T, Zerr I.

J Alzheimers Dis. 2015;43(4):1229-36. doi: 10.3233/JAD-141581.

Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor

Ferreira D, Westman E, Eyjolfsdottir H, Almqvist P, Lind G, Linderoth B, Seiger A, Blennow K, Karami A, Darreh-Shori T, Wiberg M, Simmons A, Wahlund LO, Wahlberg L, Eriksdotter M.

J Alzheimers Dis. 2015;43(3):1059-72. doi: 10.3233/JAD-141068.

Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts

Muenchhoff J, Poljak A, Song F, Raftery M, Brodaty H, Duncan M, McEvoy M, Attia J, Schofield PW, Sachdev PS.

J Alzheimers Dis. 2015;43(4):1355-73. doi: 10.3233/JAD-141266.

Memory profiles in pathology or biomarker confirmed Alzheimer disease and frontotemporal dementia

Mansoor Y, Jastrzab L, Dutt S, Miller BL, Seeley WW, Kramer JH.

Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):135-40. doi: 10.1097/WAD.0000000000000062.

Peripheral biomarkers of Alzheimer's disease

Khan TK, Alkon DL.

J Alzheimers Dis. 2015;44(3):729-44. doi: 10.3233/JAD-142262.

Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort

Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, Dallob A, Chappell D, Snyder K, Flynn M, Simon A, Modur V, Potter WZ, Wilcock G, Savage MJ, Smith AD.

J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725.

Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index

Hall A, Mattila J, Koikkalainen J, Lötjonen J, Wolz R, Scheltens P, Frisoni G, Tsolaki M, Nobili F, Freund-Levi Y, Minthon L, Frölich L, Hampel H, Visser PJ, Soininen H.

Curr Alzheimer Res. 2015;12(1):69-79. doi: 10.2174/1567205012666141218123829.

Alzheimer's disease

Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL.

Nat Rev Dis Primers. 2015 Oct 15;1:15056. doi: 10.1038/nrdp.2015.56.

Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry

Portelius E, Lashley T, Westerlund A, Persson R, Fox NC, Blennow K, Revesz T, Zetterberg H.

Neurodegener Dis. 2015;15(1):50-7. doi: 10.1159/000369465. Epub 2015 Jan 13.

Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment?

Chen J, Zhang Z, Li S.

Neurosci Bull. 2015 Feb;31(1):128-40. doi: 10.1007/s12264-014-1490-8. Epub 2015 Jan 16.

MicroRNA in vitro diagnostics using immunoassay analyzers

Kappel A, Backes C, Huang Y, Zafari S, Leidinger P, Meder B, Schwarz H, Gumbrecht W, Meese E, Staehler CF, Keller A.

Clin Chem. 2015 Apr;61(4):600-7. doi: 10.1373/clinchem.2014.232165. Epub 2015 Jan 23.

Explorative and targeted neuroproteomics in Alzheimer's disease

Brinkmalm A, Portelius E, Öhrfelt A, Brinkmalm G, Andreasson U, Gobom J, Blennow K, Zetterberg H.

Biochim Biophys Acta. 2015 Jul;1854(7):769-78. doi: 10.1016/j.bbapap.2015.01.009. Epub 2015 Jan 22.

Dementia in 2014. Towards early diagnosis in Alzheimer disease

Nordberg A.

Nat Rev Neurol. 2015 Feb;11(2):69-70. doi: 10.1038/nrneurol.2014.257. Epub 2015 Jan 27.

Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities

Reitz C.

Expert Rev Mol Diagn. 2015 Mar;15(3):339-48. doi: 10.1586/14737159.2015.1002469. Epub 2015 Jan 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias